| ID | Symbol | Description | Aliases | Front Node |
| 8648 | NCOA1 | nuclear receptor coactivator 1 | F-SRC-1, NCoA-1, RIP160, SRC1 | F |
| 10391 | CORO2B | coronin, actin binding protein, 2B | CLIPINC, KIAA0925 | T |
| 65259 | C16orf28 | chromosome 16 open reading frame 28 | FLJ23360 | T |
| 1026 | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1 | T |
| 9371 | KIF3B | kinesin family member 3B | HH0048, KIAA0359 | T |
| 11007 | DIPA | hepatitis delta antigen-interacting protein A | - | F |
| 3880 | KRT19 | keratin 19 | CK19, K19, K1CS, MGC15366 | T |
| 5366 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | APR, NOXA | T |
| 7414 | VCL | vinculin | - | T |
| 92 | ACVR2 | activin A receptor, type II | ACTRII | T |
| 8200 | GDF5 | growth differentiation factor 5 (cartilage-derived morphogenetic protein-1) | CDMP1, LAP4 | T |
| 1386 | ATF2 | activating transcription factor 2 | CRE-BP1, CREB2, HB16, TREB7 | F |
| 1958 | EGR1 | early growth response 1 | AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | T |
| 8227 | DXYS155E | DNA segment on chromosome X and Y (unique) 155 expressed sequence | 721P, MGC39904, XE7, XE7Y | T |
| 10152 | ABI2 | abl interactor 2 | ABI-2, ABI2B, AIP-1, AblBP3, SSH3BP2, argBPIA, argBPIB | F |
| 4089 | SMAD4 | SMAD, mothers against DPP homolog 4 (Drosophila) | DPC4, JIP, MADH4 | F |
| 5595 | MAPK3 | mitogen-activated protein kinase 3 | ERK1, P44ERK1, P44MAPK, PRKM3 | F |
| 3107 | HLA-C | major histocompatibility complex, class I, C | D6S204, FLJ27082, HLA-JY3 | T |
| 4286 | MITF | microphthalmia-associated transcription factor | WS2A | F |
| 22920 | KIFAP3 | kinesin-associated protein 3 | FLJ22818, KAP3, SMAP, Smg-GDS, dJ190I16.1 | T |
| 30008 | EFEMP2 | EGF-containing fibulin-like extracellular matrix protein 2 | FBLN4, UPH1 | T |
| 56159 | TEX11 | testis expressed sequence 11 | TGC1, TSGA3 | F |
| 196 | AHR | aryl hydrocarbon receptor | - | T |
| 3398 | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | ID2A, ID2H, MGC26389 | T |
| 51176 | LEF1 | lymphoid enhancer-binding factor 1 | DKFZp586H0919, TCF1ALPHA | T |
| 8061 | FOSL1 | FOS-like antigen 1 | FRA1, fra-1 | T |
| 2908 | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | GCR, GR, GRL | F |
| 4654 | MYOD1 | myogenic factor 3 | MYF3, MYOD, PUM | T |
| 4582 | MUC1 | mucin 1, transmembrane | CD227, EMA, PEM, PUM, mucin | T |
| 4739 | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | CAS-L, CASL, HEF1, dJ49G10.2, dJ761I2.1, neural | T |
| 22894 | KIAA1008 | KIAA1008 | DIS3, DKFZp667L1817, RRP44, bA555G22.1, dis3p | T |
| 8204 | NRIP1 | nuclear receptor interacting protein 1 | RIP140 | T |
| 8554 | PIAS1 | protein inhibitor of activated STAT, 1 | DDXBP1, GBP, GU/RH-II | F |
| 2516 | NR5A1 | nuclear receptor subfamily 5, group A, member 1 | AD4BP, ELP, FTZ1, FTZF1, SF-1, SF1 | F |
| 1789 | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | ICF, M.HsaIIIB | T |
| 57325 | CSRP2BP | CSRP2 binding protein | CRP2BP, MGC15388, dJ717M23.1 | T |
| 3750 | KCND1 | potassium voltage-gated channel, Shal-related subfamily, member 1 | KV4.1 | T |
| 466 | ATF1 | activating transcription factor 1 | TREB36 | F |
| 10859 | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | CD85, CD85J, ILT2, LIR-1, LIR1, MIR-7, MIR7 | F |
| 91 | ACVR1B | activin A receptor, type IB | ACTRIB, ACVRLK4, ALK4, SKR2 | F |
| 467 | ATF3 | activating transcription factor 3 | - | F |
| 1295 | COL8A1 | collagen, type VIII, alpha 1 | MGC9568 | F |
| 3603 | IL16 | interleukin 16 (lymphocyte chemoattractant factor) | FLJ44234, HsT19289, IL-16, LCF, prIL-16 | F |
| 3854 | KRT6B | keratin 6B | CK6B, K6B, KRTL1, PC2 | T |
| 1911 | PHC1 | polyhomeotic-like 1 (Drosophila) | EDR1, HPH1, RAE28 | T |
| 7329 | UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | C358B7.1, P18, UBC9 | F |
| 55081 | ESRRBL1 | estrogen-related receptor beta like 1 | FLJ10147, HIPPI, MHS4R2 | T |
| 2353 | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | - | F |
| 79696 | C14orf140 | chromosome 14 open reading frame 140 | FLJ23093 | T |
| 694 | BTG1 | B-cell translocation gene 1, anti-proliferative | - | T |
| 654 | BMP6 | bone morphogenetic protein 6 | VGR, VGR1 | T |
| 1457 | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | CK2A1, CKII, CKII alpha | F |
| 5867 | RAB4A | RAB4A, member RAS oncogene family | RAB4 | F |
| 4087 | SMAD2 | SMAD, mothers against DPP homolog 2 (Drosophila) | JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2 | F |
| 1466 | CSRP2 | cysteine and glycine-rich protein 2 | CRP2, LMO5, SmLIM | T |
| 8682 | PEA15 | phosphoprotein enriched in astrocytes 15 | HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED | T |
| 966 | CD59 | CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344) | MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN | T |
| 64780 | MICAL1 | microtubule associated monoxygenase, calponin and LIM domain containing 1 | DKFZp434B1517, FLJ11937, FLJ21739, MICAL, MICAL-1, NICAL | T |
| 54474 | KRT20 | keratin 20 | CK20, K20, KRT21, MGC35423 | T |
| 27332 | ZNF638 | zinc finger protein 638 | DKFZp686P1231, MGC26130, MGC90196, NP220, ZFML | F |
| 7709 | ZBTB17 | zinc finger and BTB domain containing 17 | MIZ1, ZNF151, pHZ-67 | F |
| 3726 | JUNB | jun B proto-oncogene | - | T |
| 4092 | SMAD7 | SMAD, mothers against DPP homolog 7 (Drosophila) | MADH7, MADH8 | T |
| 3725 | JUN | v-jun sarcoma virus 17 oncogene homolog (avian) | AP1 | T |
| 90410 | IFT20 | intraflagellar transport protein IFT20 | - | F |
| 476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | MGC3285, MGC51750 | T |
| 567 | B2M | beta-2-microglobulin | - | T |
| 3866 | KRT15 | keratin 15 | CK15, K15, K1CO | F |
| 79843 | FLJ22746 | hypothetical protein FLJ22746 | - | T |
| 27342 | RABGEF1 | RAB guanine nucleotide exchange factor (GEF) 1 | RABEX5, rabex-5 | T |